Department of Urology, Spitalzentrum Biel, Centre Hospitalier Bienne, Biel, Switzerland.
Department of Urology, Spitalzentrum Biel, Centre Hospitalier Bienne, Biel, Switzerland.
Eur Urol Focus. 2022 Mar;8(2):384-387. doi: 10.1016/j.euf.2022.04.005. Epub 2022 Apr 26.
Prostatic artery embolisation (PAE) is now endorsed by international evidence-based guidelines as a treatment for lower urinary tract symptoms presumed secondary to benign prostatic obstruction (LUTS/BPO) for selected patients. PAE is a truly minimally invasive technique, with proven efficacy and safety demonstrated for the short- to mid-term. As it has a unique treatment approach (endovascular instead of transurethral), its profile and ideal application differ clearly from other treatments for LUTS/BPO, which must be considered for patient selection. This mini review examines the role of PAE in the treatment of LUTS/BPO on the basis of current evidence. PATIENT SUMMARY: For properly selected patients, prostatic artery embolisation (PAE), in which arteries feeding the prostate are blocked in a nonsurgical procedure, is one of the treatment options for obstruction of urine outflow caused by benign enlargement of the prostate. This article examines the role of PAE according to the evidence available in the literature.
前列腺动脉栓塞术（PAE）目前被国际循证指南推荐为治疗下尿路症状（LUTS）/良性前列腺梗阻（BPO）的方法，适用于特定患者。PAE 是一种真正的微创技术，其短期至中期疗效和安全性已得到证实。由于其具有独特的治疗方法（血管内而非经尿道），因此其特征和理想应用与其他治疗 LUTS/BPO 的方法明显不同，在选择患者时必须考虑这些方法。本迷你综述根据现有证据探讨了 PAE 在 LUTS/BPO 治疗中的作用。
对于经过适当选择的患者，前列腺动脉栓塞术（PAE）是一种非手术方法，通过阻塞供应前列腺的动脉来治疗由良性前列腺增大引起的尿液流出梗阻。本文根据文献中的现有证据探讨了 PAE 的作用。
